West Pharmaceutical Services, Inc. a provider of innovative solutions for injectable drug administration, has made a strategic investment in Latch Medical, a Dublin-based provider of next-generation vaccine and biologics delivery technology that is pioneering a new approach to intradermal delivery. West will have a minority ownership stake in Latch Medical.
“West’s investment in Latch Medical advances our leadership in innovation through a dedicated focus on the needs of patients,” said Robert Segura, Vice President, Corporate Development, West Pharmaceutical Services. “The methods by which medicines are delivered to patients continue to evolve to meet their desire for ease-of-use and effectiveness. Latch Medical’s innovative intradermal-delivery technology fits well into this strategy.”
